Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patie...
Saved in:
Main Authors: | Christie Walker, Shawky Z. A. Badawy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2013/835316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effect of Vitamins C and E on Depot-Medroxyprogesterone Acetate-Induced Ovarian Oxidative Stress In Vivo
by: Atik Ismiyati, et al.
Published: (2016-01-01) -
Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
by: Vakkas Korkmaz, et al.
Published: (2013-08-01) -
Reproductive and growth performances in female giant freshwater prawn following inhibition of gonadal maturation using dopamine and medroxyprogesterone hormone
by: Megawati Wijaya, et al.
Published: (2020-02-01) -
Causal ACTH-Depot Therapy during Pregnancies following Infertility Treatment
by: Rudolf Klimek, et al.
Published: (2012-01-01) -
Vaginal Extrusion of Transobturator Tape 6 Years after Procedure: How Long Should Be the Follow-Up Period after Vaginal Sling Surgeries?
by: Chanchal Singh, et al.
Published: (2012-01-01)